Araştırma Makalesi

Investigation of The Effect of Intermediate Dose Calculation Module on Dose Dıstrıbutıon in Lung Cancer Radiotherapy Patients

Cilt: 5 Sayı: 3 30 Kasım 2019
PDF İndir
EN

Investigation of The Effect of Intermediate Dose Calculation Module on Dose Dıstrıbutıon in Lung Cancer Radiotherapy Patients

Abstract

The aim of this study was to investigate the effect of the use of intermediate dose calculation module on dose volume histogram (DVH) during dose optimization in the treatment plans of radiotherapy patients diagnosed with lung cancer.

This study was carried out by using Eclipse (Version 15.3) treatment planning system with Trilogy model Linear Accelerator device in Radiation Oncology Department of Şişli Hamidiye Etfal Training and Research Hospital. Ten patients with lung cancer were included in the study. In this study, critical organ doses, conformity index (CI) and homogenity index (HI) were compared by making optimization in cases where intermediate dose calculation module was active and inactive.

The plans using the Intermediate dose calculation model are more homogeneous and uniform. Differences between critical organ doses, conformity index (CI) and homogenity index (HI) were statistically significant when using the Intermediate dose calculation module.

It has been demonstrated that the intermediate dose calculation method in heterogeneous lung cancer patients is superior in terms of dose homogeneity and tumor volume enveloping, which improves the quality of treatment plans.

Keywords

Kaynakça

  1. [1] S.G. Spiro, J.C. Porter; “Lung cancer-Where are we today? Current advances in staging and nonsurgical treatment” Am J Respir Crit Care Med. 166:1166–1196. (2002).
  2. [2] G.M. Parkin, P. Pisani, J. Ferlay; “Global cancer statistics” CA Cancer J Clin 49:33-6 (1999).
  3. [3] M. Hattori, M. Fujita, Y. Ito, et. al.; “Use of a Population-Based Cancer Registry to Calculate Twenty-Year Trends in Cancer Incidence and Mortality in Fukui Prefecture” J Epidemiol (2010).
  4. [4] P. Pisani, D.M. Parkin, F. Bray, J. Ferlay; Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83:18-29 (1999).
  5. [5] Sağlık Bakanlığı Kanser İstatistikleri, (2017).
  6. [6] M. Gültekin, H. Bilge, Ş.Ç. Gökçe ş, G. Özyiğit, O.G. Yıldız, Temel Ve Klinik Radyoterapi, 1. Baskı, İzmir, Hürriyet Matbaa, s.239 (2013).
  7. [7] L.J. Machlın, and A. Pendıch; “Free radical tissue damage. protective role of antioxidant nutrients” Faseb Journal 441-445 (1987).
  8. [8] M.S. Hug, Y. Yu, Z.P. Chan, and N. Suntharalıngam “Dosimetrics characteristics of commercial multileaf collimator” Medical Physics 241 – 247(1995).

Ayrıntılar

Birincil Dil

İngilizce

Konular

Klinik Tıp Bilimleri

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

30 Kasım 2019

Gönderilme Tarihi

30 Eylül 2019

Kabul Tarihi

31 Ekim 2019

Yayımlandığı Sayı

Yıl 2019 Cilt: 5 Sayı: 3

Kaynak Göster

APA
Yahşi Çelen, Y., & Kızılkaya, H. O. (2019). Investigation of The Effect of Intermediate Dose Calculation Module on Dose Dıstrıbutıon in Lung Cancer Radiotherapy Patients. International Journal of Computational and Experimental Science and Engineering, 5(3), 142-146. https://doi.org/10.22399/ijcesen.626510